Traumatic SCI with disease duration = 6 months
Conditions
Interventions
Contrlo group:Receive standard SCS treatment with fixed stimulation parameters of frequency 40Hz, intensity 200µA, and pulse width 200µs, five times per week, 30 mi
Experimental group:Receive dynamic SCS treatment based on multidimensional assessments (pain, motor function, quality of life) and an AI prediction model. Stimulation pa
Sponsors
The First Affiliated Hospital Of Xinjiang Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Inclusion criteria for the experimental study: aged 18–65 years; traumatic spinal cord injury (SCI) with a disease course of =18 years; diagnosed with traumatic or non-traumatic spinal cord injury (SCI); have received spinal cord stimulation (SCS) therapy and completed at least 6 months of follow-up; and have complete medical records, including preoperative evaluation, surgical records, stimulation parameters, and follow-up documentation.
Exclusion criteria
Exclusion criteria: 1.Inclusion criteria for the experimental study: Severe cardiac, pulmonary, hepatic, or renal insufficiency, or malignant tumors Bleeding tendency, coagulation disorders, or current use of anticoagulant medications Spinal infection, skin breakdown, or infection at the implant site Presence of implanted electronic devices (e.g., cardiac pacemaker) Pregnancy or breastfeeding Participation in other clinical trials that may interfere with the outcomes of this study; 2.Exclusion criteria for the retrospective study: incomplete medical records or missing key data; receipt of other neuromodulation or surgical interventions (e.g., intrathecal pump, rhizotomy, etc.) during SCS therapy; loss to follow-up or follow-up duration of less than 6 months. Follow-up data: pain scores (VAS, NRS), motor function (MAS, manual muscle testing), quality of life scores (SCI-QOL), and complication records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate of pain relief;Motor function improvement rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity;Quality of Life;Neuroimaging indicators;Neurophysiological indicators;Motor function;Safety measures; | — |
Countries
China
Contacts
Public ContactKun Luo
The First Affiliated Hospital Of Xinjiang Medical University
Outcome results
None listed